These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19122)

  • 1. Increased exercise tolerance with nitrates in beta-blockaded patients with angina.
    Baxter RH; Lennox IM
    Br Med J; 1977 Aug; 2(6086):550-2. PubMed ID: 19122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease.
    Glancy DL; Richter MA; Ellis EV; Johnson W
    Am J Med; 1977 Jan; 62(1):39-46. PubMed ID: 319662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new oral slow release form of isosorbide dinitrate. Effect on the hemodynamics and exercise capacity of patients with angina.
    Di Bianco R; Ronan JA; Donohue DJ; Lindgren KM
    Chest; 1983 Dec; 84(6):707-13. PubMed ID: 6641305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ergometric study of the association of a beta-blocker and a nitrate derivative].
    Jullien G
    Nouv Presse Med; 1978 Sep; 7(31):2727-31. PubMed ID: 30951
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and circulatory effects of oral isosorbide dinitrate in patients with angina during exercise.
    Lauwers PL; Tackels R
    Acta Cardiol; 1975; 30(4):293-312. PubMed ID: 1084659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal effect of isosorbide dinitrate spray in patients with exercise-induced stable angina.
    Aärynen M; Soininen K
    J Int Med Res; 1986; 14(6):303-5. PubMed ID: 3803701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacy of nisoldipine, metoprolol, and isosorbide dinitrate in patients with stable exertional angina: a randomized, cross-over, placebo-controlled study.
    Ogawa H; Yasue H; Nakamura N; Fujii H; Miyagi H; Kikuta K
    Int J Cardiol; 1995 Feb; 48(2):131-7. PubMed ID: 7774991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isosorbide dinitrate in clinical practice.
    Swedberg K
    Scand J Clin Lab Invest Suppl; 1984; 173():85-91. PubMed ID: 6152077
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic acitivity in patients with angina pectoris.
    Battock DJ; Alvarez H; Chidsey CA
    Circulation; 1969 Feb; 39(2):157-69. PubMed ID: 4884575
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-anginal efficacy of a controlled-release formulation of isosorbide-5-mononitrate once daily in angina patients on chronic beta-blockade.
    Uusitalo A; Keyriläinen O; Härkönen R; Rautio P; Rehnqvist N; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G
    Acta Med Scand; 1988; 223(3):219-25. PubMed ID: 2895564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antianginal efficacy of isosorbide dinitrate therapy is maintained during diuretic treatment.
    Sussex BA; Campbell NR; Raju MK; McKay DW
    Clin Pharmacol Ther; 1994 Aug; 56(2):229-34. PubMed ID: 8062500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation.
    Tirlapur VG; Mir MA
    Postgrad Med J; 1983; 59 Suppl 2():30-4. PubMed ID: 6136959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separate and combined effects of pindolol and isosorbide dinitrate in standardized exercise tests of patients with angina pectoris.
    Zetterquist S; Furberg C; Ringqvist I; Söderholm B
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):139-48. PubMed ID: 803427
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of sorbonite on exercise tolerance in stable angina pectoris].
    Juszczyk Z
    Pol Tyg Lek; 1982 May; 37(11):301-4. PubMed ID: 7122293
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of isosorbide-5-mononitrate (5-ISMN) Durules on exercise tolerance in patients with exertional angina pectoris. A placebo controlled study.
    Nyberg G; Carlens P; Lindström E; Lundman T; Nordlander R; Rehnqvist N; Ulvenstam G; Aberg A; Aström H
    Eur Heart J; 1986 Oct; 7(10):835-42. PubMed ID: 3539613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin.
    Goldstein RE; Rosing DR; Redwood DR; Beiser GD; Epstein SE
    Circulation; 1971 May; 43(5):629-40. PubMed ID: 4996159
    [No Abstract]   [Full Text] [Related]  

  • 18. Importance of coronary collateral circulation for increased treadmill exercise capacity by nitrates in patients with stable effort angina pectoris.
    Ohno A; Fujita M; Miwa K; Ejiri M; Asanoi H; Sasayama S
    Cardiology; 1991; 78(4):323-8. PubMed ID: 1889050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.
    Turner GG; Nelson RR; Nordstrom LA; Diefenthal HC; Gobel FL
    Br Heart J; 1978 Dec; 40(12):1361-70. PubMed ID: 32899
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term percutaneous therapy of angina pectoris with isosorbide dinitrate with reference to isosorbide dinitrate blood levels].
    Kriehuber E; Prey T; Orthofer R
    Wien Med Wochenschr; 1982 Jun; 132(12):295-302. PubMed ID: 7123974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.